Health
1 read
Xanax XR Recall: FDA Alerts Patients Over Quality Issues

Want the full story?
Read the complete article at KTSM
AI Summary
The FDA has announced a Class II recall for a specific lot of Xanax XR (alprazolam) extended-release tablets due to quality concerns that may impact the medication's effectiveness. This recall is significant as it affects patients relying on this medication for anxiety and panic disorders. Patients are advised to check their prescriptions and consult with healthcare providers regarding any concerns or alternative treatments. The recall underscores the importance of monitoring medication quality to ensure patient safety.
health fda medication recall
People & Organizations
U.S. Food and Drug Administration